In this study, treatment with AA improved symptoms of obesity‐linked metabolic syndrome, including adipocyte differentiation and elevated levels of lipids, glucose, and insulin (Figures 1, 2, 3, 4), similar to results from previous studies. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.